$9.79
0.313.27%
Last update: Nov 9, 4:00 PM

The average analyst price target for Turn Therapeutics is $14, 42.9% above the current price. Of 3 analysts, 2 rate it Buy and 1 Hold. Targets range from $8 to $24. The latest change came on Oct 23, 2026, when WBB Securities upgraded Turn Therapeutics from Sell to Hold with a $10 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months